Efficacy of combined surgery and pembrolizumab for the treatment of pulmonary large cell carcinoma: a case report
Pulmonary large cell carcinoma (LCC) is a rare and aggressive subtype of non-small cell lung cancer (NSCLC) with poor prognosis. Surgical resection remains the cornerstone of treatment for resectable LCC; however, its efficacy is limited in advanced stages, necessitating adjuvant therapies to reduce...
Saved in:
| Main Authors: | Linguo Gu, Hongzuo Chen, Zhenkun Xia, Bei Qing, Yunchang Yuan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1500996/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Response of EGFR-mutated pulmonary pleomorphic carcinoma to pembrolizumab
by: Yuki Hatakeyama, et al.
Published: (2025-01-01) -
Continuous remission of single-mode therapy with pembrolizumab plus chemotherapy in locally advanced hypopharyngeal carcinoma: a case report
by: Guoning Yu, et al.
Published: (2025-06-01) -
Bronchoscopic Interventional Therapy Combined With Pembrolizumab in the Treatment of Pulmonary Large Cell Neuroendocrine Carcinoma: A Case Report
by: Yingyi Fan, et al.
Published: (2024-09-01) -
Successful treatment of recurrent unresectable squamous cell carcinoma of the head and neck using pembrolizumab
by: A. M. Mudunov, et al.
Published: (2019-04-01) -
Pulmonary NUT carcinoma, an elusive and refractory entity, shows transient response to chemotherapeutics and PD-1 inhibitor: a case report and literature review
by: Guangjian Yang, et al.
Published: (2025-03-01)